"Unnamed: 0","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","12/88","102/10891",2.67896633156917e-11,6.94693305241331e-09,5.06452995452114e-09,"CD27/LTBR/TNF/TNFRSF11A/TNFRSF12A/TNFRSF13B/TNFRSF14/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFRSF6B/TNFRSF9",12
"R-HSA-5669034","R-HSA-5669034","TNFs bind their physiological receptors","8/88","29/10891",4.90949332326029e-11,6.94693305241331e-09,5.06452995452114e-09,"CD27/TNFRSF13B/TNFRSF14/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFRSF6B/TNFRSF9",8
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","10/88","125/10891",5.85110900651011e-08,5.51954616280787e-06,4.02392057991573e-06,"CKAP4/CSF1/CST3/FGF23/FSTL3/IGFBP4/IGFBP6/IGFBP7/SHISA5/SPP1",10
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","9/88","108/10891",1.97144548050661e-07,1.39479767745843e-05,1.01685082678762e-05,"CKAP4/CSF1/CST3/FGF23/FSTL3/IGFBP4/IGFBP7/SHISA5/SPP1",9
"R-HSA-216083","R-HSA-216083","Integrin cell surface interactions","8/88","85/10891",3.81340920662916e-07,2.15838961095211e-05,1.57353306210382e-05,"AGRN/BSG/COL18A1/COL6A3/HSPG2/ITGA11/JAM2/SPP1",8
"R-HSA-198933","R-HSA-198933","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell","8/88","134/10891",1.19769677410617e-05,0.00056491364512007,0.00041183959249966,"CD300C/CD300E/COLEC12/HLA-E/LAIR1/NECTIN2/NPDC1/PILRA",8
"R-HSA-9694614","R-HSA-9694614","Attachment and Entry","4/88","19/10891",1.40601079342354e-05,0.00056843007791266,0.00041440318121957,"AGRN/HAVCR1/HSPG2/SDC1",4
"R-HSA-3560782","R-HSA-3560782","Diseases associated with glycosaminoglycan metabolism","5/88","41/10891",1.83022393049651e-05,0.00064744171541314,0.00047200511891752,"AGRN/B4GALT1/HSPG2/OGN/SDC1",5
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","11/88","300/10891",2.79589395081944e-05,0.000879153320091,0.00064093007527556,"AGRN/BSG/COL18A1/COL6A3/CTSS/HSPG2/ITGA11/JAM2/MMP7/SDC1/SPP1",11
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","5/88","47/10891",3.60629312570173e-05,0.00102058095457359,0.00074403521330267,"CSF1/IL10RB/TNF/TNFRSF1A/TNFRSF1B",5
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","5/88","51/10891",5.38428033629807e-05,0.00138522848652032,0.00100987458939179,"EFNA1/EFNA4/EPHA2/EPHB4/EPHB6",5
"R-HSA-1474228","R-HSA-1474228","Degradation of the extracellular matrix","7/88","140/10891",0.00013308032640512,0.00313847769772091,0.00228804771714078,"BSG/COL18A1/COL6A3/CTSS/HSPG2/MMP7/SPP1",7
"R-HSA-3656237","R-HSA-3656237","Defective EXT2 causes exostoses 2","3/88","14/10891",0.00017398429125016,0.0035169681731283,0.00256397902894978,"AGRN/HSPG2/SDC1",3
"R-HSA-3656253","R-HSA-3656253","Defective EXT1 causes exostoses 1, TRPS2 and CHDS","3/88","14/10891",0.00017398429125016,0.0035169681731283,0.00256397902894978,"AGRN/HSPG2/SDC1",3
"R-HSA-9772572","R-HSA-9772572","Early SARS-CoV-2 Infection Events","4/88","38/10891",0.000238171354265,0.00449349955046636,0.00327590073234669,"AGRN/HAVCR1/HSPG2/SDC1",4
"R-HSA-5676594","R-HSA-5676594","TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway","3/88","18/10891",0.00038101224775318,0.00673915413213445,0.00491305266839632,"LTBR/TNFRSF11A/TNFRSF12A",3
"R-HSA-3560783","R-HSA-3560783","Defective B4GALT7 causes EDS, progeroid type","3/88","20/10891",0.00052611262453279,0.00783630909172532,0.00571291270960819,"AGRN/HSPG2/SDC1",3
"R-HSA-3560801","R-HSA-3560801","Defective B3GAT3 causes JDSSDHD","3/88","20/10891",0.00052611262453279,0.00783630909172532,0.00571291270960819,"AGRN/HSPG2/SDC1",3
"R-HSA-4420332","R-HSA-4420332","Defective B3GALT6 causes EDSP2 and SEMDJL1","3/88","20/10891",0.00052611262453279,0.00783630909172532,0.00571291270960819,"AGRN/HSPG2/SDC1",3
"R-HSA-2024096","R-HSA-2024096","HS-GAG degradation","3/88","22/10891",0.00070246236216387,0.00993984242461887,0.00724645384126948,"AGRN/HSPG2/SDC1",3
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","6/88","137/10891",0.00082652617962335,0.0111384242301623,0.00812025720331714,"BSG/CD74/JAM2/SDC1/TNFRSF10A/TNFRSF10B",6
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","5/88","92/10891",0.00086968118071752,0.0111872624610481,0.00815586179046097,"EFNA1/EFNA4/EPHA2/EPHB4/EPHB6",5
"R-HSA-449836","R-HSA-449836","Other interleukin signaling","3/88","24/10891",0.00091252485063935,0.0112280231622147,0.00818557760756588,"CSF1/IL10RB/SDC1",3
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","6/88","143/10891",0.00103341817083904,0.0121857225978104,0.00888377024054617,"AGRN/B4GALT1/HSPG2/OGN/SDC1/SPON2",6
"R-HSA-1971475","R-HSA-1971475","A tetrasaccharide linker sequence is required for GAG synthesis","3/88","26/10891",0.00115862472736509,0.0131156319137729,0.00956170301320246,"AGRN/HSPG2/SDC1",3
"R-HSA-2022090","R-HSA-2022090","Assembly of collagen fibrils and other multimeric structures","4/88","61/10891",0.00146212597863063,0.0159146789212487,0.0116022952150446,"COL18A1/COL6A3/CTSS/MMP7",4
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","11/88","482/10891",0.00166893710019078,0.017492933309407,0.0127528916817697,"B4GALT1/CD59/CKAP4/CST3/CTSS/LAIR1/PIGR/PLAUR/RNASET2/SIRPB1/TNFRSF1B",11
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","3/88","30/10891",0.0017675684304558,0.0178650666363926,0.0130241884349375,"EFNA1/EFNA4/EPHA2",3
"R-HSA-2022928","R-HSA-2022928","HS-GAG biosynthesis","3/88","31/10891",0.00194559406947209,0.0189863145400207,0.0138416129806363,"AGRN/HSPG2/SDC1",3
"R-HSA-1630316","R-HSA-1630316","Glycosaminoglycan metabolism","5/88","124/10891",0.00325521592158311,0.028183267135199,0.0205464770634145,"AGRN/B4GALT1/HSPG2/OGN/SDC1",5
"R-HSA-1236977","R-HSA-1236977","Endosomal/Vacuolar pathway","2/88","11/10891",0.00338597555687903,0.028183267135199,0.0205464770634145,"CTSS/HLA-E",2
"R-HSA-3371378","R-HSA-3371378","Regulation by c-FLIP","2/88","11/10891",0.00338597555687903,0.028183267135199,0.0205464770634145,"TNFRSF10A/TNFRSF10B",2
"R-HSA-5218900","R-HSA-5218900","CASP8 activity is inhibited","2/88","11/10891",0.00338597555687903,0.028183267135199,0.0205464770634145,"TNFRSF10A/TNFRSF10B",2
"R-HSA-69416","R-HSA-69416","Dimerization of procaspase-8","2/88","11/10891",0.00338597555687903,0.028183267135199,0.0205464770634145,"TNFRSF10A/TNFRSF10B",2
"R-HSA-6803211","R-HSA-6803211","TP53 Regulates Transcription of Death Receptors and Ligands","2/88","12/10891",0.00404189191023738,0.0326815831599194,0.0238258891550835,"TNFRSF10A/TNFRSF10B",2
"R-HSA-419037","R-HSA-419037","NCAM1 interactions","3/88","42/10891",0.00466141044148245,0.0353882603365282,0.0257991408813819,"AGRN/COL6A3/GFRA1",3
"R-HSA-190375","R-HSA-190375","FGFR2c ligand binding and activation","2/88","13/10891",0.00475178053988717,0.0353882603365282,0.0257991408813819,"FGF23/FGFR2",2
"R-HSA-5357786","R-HSA-5357786","TNFR1-induced proapoptotic signaling","2/88","13/10891",0.00475178053988717,0.0353882603365282,0.0257991408813819,"TNF/TNFRSF1A",2
"R-HSA-975634","R-HSA-975634","Retinoid metabolism and transport","3/88","44/10891",0.0053157075532569,0.0385729548095308,0.0281208820631134,"AGRN/HSPG2/SDC1",3
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","5/88","141/10891",0.00561787383235076,0.0390851184168925,0.0284942652397654,"RTN4R/TNF/TNFRSF10A/TNFRSF10B/TNFRSF1A",5
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","3/88","45/10891",0.00566250832188195,0.0390851184168925,0.0284942652397654,"CD300E/HLA-E/SIRPB1",3
"R-HSA-1474290","R-HSA-1474290","Collagen formation","4/88","90/10891",0.00599760891506311,0.0404124600705443,0.0294619385301346,"COL18A1/COL6A3/CTSS/MMP7",4
"R-HSA-6806667","R-HSA-6806667","Metabolism of fat-soluble vitamins","3/88","48/10891",0.00678314501169808,0.044642559030478,0.0325458120512319,"AGRN/HSPG2/SDC1",3
"R-HSA-1793185","R-HSA-1793185","Chondroitin sulfate/dermatan sulfate metabolism","3/88","50/10891",0.00759833766060623,0.048871126317081,0.0356285689349,"AGRN/HSPG2/SDC1",3
"R-HSA-140534","R-HSA-140534","Caspase activation via Death Receptors in the presence of ligand","2/88","17/10891",0.0081133196435893,0.0499145534594733,0.0363892597286843,"TNFRSF10A/TNFRSF10B",2
"R-HSA-2033519","R-HSA-2033519","Activated point mutants of FGFR2","2/88","17/10891",0.0081133196435893,0.0499145534594733,0.0363892597286843,"FGF23/FGFR2",2
